CSP Versus BiVP for Heart Failure Patients With RVP Upgraded to Cardiac Resynchronization Therapy
NCT: NCT06241651 · RECRUITING
広告
NCT識別子NCT06241651
ステータスRECRUITING
開始日2024-01-01
SponsorThe First Affiliated Hospital with Nanjing Medical University (OTHER)
First posted
Last updated
概要
The present study is a prospective, multicenter, non-inferiority, randomized controlled trail. It aims to investigate whether the efficacy of conduction system pacing (CSP) is non-inferior to biventricular pacing (BiVP) in patients with heart failure and right ventricular pacing (RVP) requiring upgrading to cardiac resynchronization therapy (CRT).
公式ソース
ClinicalTrials.govで見る →データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。